Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BGM
3026
BGM Group Ltd
BGM
$144M
| $317K | ﹤0.01% |
999
+556
| +126% | +$202K |
2025 Q1
1 quarter
|
|
3027
EverCommerce
EVCM
$1.61B
| $316K | ﹤0.01% |
30,100
+6,400
| +27% | +$64.6K |
2024 Q1
5 quarters
|
|
|
DFUS
3028
Dimensional US Equity ETF
DFUS
$21.8B
| $315K | ﹤0.01% |
4,700
-9,500
| -67% | -$588K |
2023 Q3
7 quarters
|
|
|
STR
3029
DELISTED
Sitio Royalties
STR
| $312K | ﹤0.01% |
+17,000
| New | +$305K |
2025 Q2
0 quarters
|
|
3030
Vanguard Real Estate ETF
VNQ
$35.8B
| $312K | ﹤0.01% |
+3,500
| New | +$309K |
2025 Q2
0 quarters
|
|
3031
Pixelworks
PXLW
$35.9M
| $311K | ﹤0.01% |
44,562
-152
| -0.3% | -$978 |
2015 Q4
38 quarters
|
|
|
LESL
3032
DELISTED
Leslie's
LESL
| $311K | ﹤0.01% |
37,000
-110,095
| -75% | -$1.45M |
2024 Q3
3 quarters
|
|
3033
Scully Royalty
SRL
$77.7M
| $310K | ﹤0.01% |
53,414
-4,500
| -8% | -$31.8K |
2013 Q2
48 quarters
|
|
3034
Mannatech
MTEX
$15.2M
| $308K | ﹤0.01% |
32,978
+100
| +0.3% | +$984 |
2018 Q3
27 quarters
|
|
3035
McEwen Inc
MUX
$1.1B
| $305K | ﹤0.01% |
31,768
-23,142
| -42% | -$189K |
2024 Q1
5 quarters
|
|
3036
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.15B
| $305K | ﹤0.01% |
3,800
-5,800
| -60% | -$431K |
2024 Q3
3 quarters
|
|
|
GLDG
3037
GoldMining Inc
GLDG
$192M
| $303K | ﹤0.01% |
420,930
+144,160
| +52% | +$112K |
2023 Q4
6 quarters
|
|
3038
Amplify Cybersecurity ETF
HACK
$3.6B
| $302K | ﹤0.01% |
+3,500
| New | +$273K |
2025 Q2
0 quarters
|
|
|
SUNS
3039
Sunrise Realty Trust
SUNS
$79.1M
| $300K | ﹤0.01% |
28,297
-45,303
| -62% | -$469K |
2024 Q4
2 quarters
|
|
|
XOMA
3040
DELISTED
Xoma
XOMA
| $300K | ﹤0.01% |
11,900
-1,800
| -13% | -$43.1K |
2024 Q3
3 quarters
|
|
|
BCAB
3041
DELISTED
BIOATLA INC
BCAB
| $299K | ﹤0.01% |
15,085
+188
| +1% | +$3.81K |
2021 Q4
14 quarters
|
|
3042
Lisata Therapeutics
LSTA
$11.5M
| $298K | ﹤0.01% |
102,822
+100
| +0.1% | +$240 |
2016 Q2
36 quarters
|
|
3043
S&T Bancorp
STBA
$1.69B
| $295K | ﹤0.01% |
+7,800
| New | +$285K |
2025 Q2
0 quarters
|
|
3044
Foghorn Therapeutics
FHTX
$119M
| $294K | ﹤0.01% |
62,636
+5,400
| +9% | +$22.6K |
2024 Q2
4 quarters
|
|
3045
Highway Holdings
HIHO
$3.98M
| $294K | ﹤0.01% |
169,915
-4,600
| -3% | -$7.82K |
2013 Q2
48 quarters
|
|
3046
VirTra
VTSI
$30.4M
| $293K | ﹤0.01% |
41,500
-15,097
| -27% | -$79.5K |
2021 Q3
15 quarters
|
|
3047
Actinium Pharmaceuticals
ATNM
$34.6M
| $293K | ﹤0.01% |
209,501
+151,901
| +264% | +$227K |
2024 Q2
4 quarters
|
|
|
OKUR
3048
OnKure Therapeutics
OKUR
$97.6M
| $293K | ﹤0.01% |
122,636
+80,773
| +193% | +$212K |
2022 Q2
12 quarters
|
|
3049
Greif
GEF
$4.65B
| $292K | ﹤0.01% |
+4,500
| New | +$256K |
2025 Q2
0 quarters
|
|
3050
Global Payments
GPN
$21.8B
| $292K | ﹤0.01% |
3,649
-87,800
| -96% | -$6.95M |
2025 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.